A secret group of traders has been using inside information to make a killing from market moving events, including Trump’s tweets. At least that’s sure what it looks like to us. And that’s unfortunately something the average investor can’t do.…
Short Sellers Continue to Pile Into These 4 Marijuana Stocks
For years, marijuana stocks could no wrong. But that’s not the case any longer. Now that recreational pot is legalized in Canada, promises don’t hold the clout they once did with Wall Street and investors. Rather, investors are looking for…
The Legal Cannabis Company Going Up Against the Black Market
Last month, when we talked about the $4 trillion potential of a fully realized global cannabis market, we saw how world governments have been trying for more than 100 years to stamp out the illicit drug trade. Results have been…
Is GW Pharmaceuticals an Opportunity Before Earnings?
GW Pharmaceuticals (NASDAQ:GWPH), a U.K.-based company, is a biotech that has pioneered the medical cannabis field and is capitalizing on its first-mover advantage. Founded in 1998, biotech veterans Dr. Geoffrey Guy and Dr. Brian Whittle worked closely with U.K. regulatory…
IRS “Guidance” for Taxes on Cryptocurrency Just Raises More Questions
Following through on a promise made in May, the IRS this month issued long-awaited guidance on how investors should treat taxes on cryptocurrency. Unfortunately, the new “guidance” clarified little. It ignored several key issues and left investors with more questions…
3 Beaten-Down Cannabis Stocks Likely to Bounce Back in a Big Way
A not-so-long time ago, cannabis stocks were sizzling hot. Many of them were also overhyped. This led to the inevitable industrywide decline as cannabis stocks fell out of favor. Investors realized that the sky-high sales and profits they expected could…
